ERS Genomics & abm enter into CRISPR/Cas9 Licensing Agreement
This License allows abm to develop and commercialize products using CRISPR/Cas9 technology. DUBLIN and VANCOUVER, BC, June 1, 2023 /PRNewswire/ — ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Applied Biological Materials Inc (‘abm,’). This is a non-exclusive licensing agreement granting abm access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by … Read more